Fair value measurement (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
| Fair Value Disclosures [Abstract] |
|
| Schedule of Corporation’s Assets and Liabilities Measured at Fair Value on a Recurring Basis |
The following fair value hierarchy tables present information about the Corporation’s assets and liabilities measured at fair value on a recurring basis at June 30, 2026 and December 31, 2025: | | | | | | | | | | | | | | | | RECURRING FAIR VALUE MEASUREMENTS | | | | | | | | | | | | Debt securities available-for-sale: | | | | | | | | | | | | Collateralized mortgage obligations - federal agencies | | | | | | Mortgage-backed securities | | | | | | | | | | | | Total debt securities available-for-sale | | | | | | Trading account debt securities, excluding derivatives: | | | | | | | | | | | | Obligations of Puerto Rico, States and political subdivisions | | | | | | Collateralized mortgage obligations | | | | | | Mortgage-backed securities | | | | | | | | | | | | Total trading account debt securities, excluding derivatives | | | | | | | | | | | | Mortgage servicing rights | | | | | | | | | | | | | | | | | | Total assets measured at fair value on a recurring basis | | | | | | | | | | | | | | | | | | Total liabilities measured at fair value on a recurring basis | | | | | |
| | | | | | | | | | | | | | | | RECURRING FAIR VALUE MEASUREMENTS | | | | | | | | | | | | Debt securities available-for-sale: | | | | | | | | | | | | Collateralized mortgage obligations - federal agencies | | | | | | Mortgage-backed securities | | | | | | | | | | | | Total debt securities available-for-sale | | | | | | Trading account debt securities, excluding derivatives: | | | | | | | | | | | | Obligations of Puerto Rico, States and political subdivisions | | | | | | Collateralized mortgage obligations | | | | | | Mortgage-backed securities | | | | | | | | | | | | Total trading account debt securities, excluding derivatives | | | | | | | | | | | | Mortgage servicing rights | | | | | | | | | | | | | | | | | | Total assets measured at fair value on a recurring basis | | | | | | | | | | | | | | | | | | Total liabilities measured at fair value on a recurring basis | | | | | |
|
| Schedule of Loans Held-For-Sale Measured at Fair Value |
The following tables summarize the difference between the aggregate fair value and the aggregate unpaid principal balance for loans held- for-sale measured under the fair value option as of June 30, 2026 and December 31, 2025. | | | | | | | | Aggregate Unpaid Principal Balance | | | | | |
| | | | | | | | Aggregate Unpaid Principal Balance | | | | | |
|
| Schedule of Nonrecurring Fair Value Measurements |
The fair value information included in the following tables is not as of period end, but as of the date that the fair value measurement was recorded during the six months ended June 30, 2026 and 2025 and excludes nonrecurring fair value measurements of assets no longer outstanding as of the reporting date. | | | | | | Six months ended June 30, 2026 | | | | | | | NONRECURRING FAIR VALUE MEASUREMENTS | | | | | | | | | | | | Loans held-in-porfolio [1] | | | | | | | | | | | | Other real estate owned [3] | | | | | | Other foreclosed assets [3] | | | | | | Total assets measured at fair value on a nonrecurring basis | | | | | |
[1]Relates mainly to certain impaired collateral dependent loans. The impairment was measured based on the fair value of the collateral, which is derived from appraisals that take into consideration prices in observed transactions involving similar assets in similar locations. Costs to sell are excluded from the reported fair value amount. [2]Relates to impaired commercial loan for which the Corporation has the intent to sell as of June 30, 2026. [3]Represents the fair value of foreclosed real estate and other collateral owned that were written down to their fair value. Costs to sell are excluded from the reported fair value amount. | | | | | | Six months ended June 30, 2025 | | | | | | | | | | | | | NONRECURRING FAIR VALUE MEASUREMENTS | | | | | | | | | | | | | | | | | | Other real estate owned [2] | | | | | | Other foreclosed assets [2] | | | | | | Total assets measured at fair value on a nonrecurring basis | | | | | |
[1]Relates mainly to certain impaired collateral dependent loans. The impairment was measured based on the fair value of the collateral, which is derived from appraisals that take into consideration prices in observed transactions involving similar assets in similar locations. Costs to sell are excluded from the reported fair value amount. [2]Represents the fair value of foreclosed real estate and other collateral owned that were written down to their fair value. Costs to sell are excluded from the reported fair value amount.
|
| Schedule of Changes in Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis |
The following tables present the changes in Level 3 assets and liabilities measured at fair value on a recurring basis for the quarters and six months ended June 30, 2026 and 2025. | | | | | | | Quarters ended June 30, 2026 | | MBS classified as debt securities available- for-sale | Other securities classified as debt securities available- for-sale | MBS classified as trading account debt securities | Other securities classified as trading account debt securities | | | Balance at March 31, 2026 | | | | | | | Gains (losses) included in earnings | | | | | | | | | | | | | | | | | | | | | | | | | | | | Changes in unrealized gains (losses) included in earnings relating to assets still held at June 30, 2026 | | | | | | |
| | | | | | | Six months ended June 30, 2026 | | MBS classified as debt securities available- for-sale | Other securities classified as debt securities available- for-sale | MBS classified as trading account debt securities | Other securities classified as trading account debt securities | | | Balance at January 1, 2026 | | | | | | | Gains (losses) included in earnings | | | | | | | Gains (losses) included in OCI | | | | | | | | | | | | | | | | | | | | | | | | | | | | Changes in unrealized gains (losses) included in earnings relating to assets still held at June 30, 2026 | | | | | | |
| | | | | | | Quarter ended June 30, 2025 | | MBS classified as debt securities available- for-sale | Other securities classified as debt securities available- for-sale | MBS classified as trading account debt securities | Other securities classified as trading account debt securities | | | Balance at March 31, 2025 | | | | | | | Gains (losses) included in earnings | | | | | | | Gains (losses) included in OCI | | | | | | | | | | | | | | | | | | | | | | | | | | | | Changes in unrealized gains (losses) included in earnings relating to assets still held at June 30, 2025 | | | | | | |
| | | | | | | | Six months ended June 30, 2025 | | MBS classified as debt securities available- for-sale | Other securities classified as debt securities available- for-sale | CMOs classified as trading account debt securities | MBS classified as trading account securities | Other securities classified as trading account debt securities | | | Balance at January 1, 2025 | | | | | | | | Gains (losses) included in earnings | | | | | | | | Gain (losses) included in OCI | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Changes in unrealized gains (losses) included in earnings relating to assets still held at June 30, 2025 | | | | | | | |
|
| Schedule of Gains and Losses (Realized and Unrealized) Included in Earnings |
Gains and losses (realized and unrealized) included in earnings for the quarters and six months ended June 30, 2026 and 2025 for Level 3 assets and liabilities included in the previous tables are reported in the Consolidated Statements of Operations as follows: | | | | | | Quarter ended June 30, 2026 | Six months ended June 30, 2026 | | Total gains (losses) included in earnings | Changes in unrealized gains (losses) relating to assets still held at reporting date | Total gains (losses) included in earnings | Changes in unrealized gains (losses) relating to assets still held at reporting date | Mortgage banking activities | | | | | Trading account profit (loss) | | | | | | | | | |
| | | | | | Quarter ended June 30, 2025 | Six months ended June 30, 2025 | | Total gains (losses) included in earnings | Changes in unrealized gains (losses) relating to assets still held at reporting date | Total gains (losses) included in earnings | Changes in unrealized gains (losses) relating to assets still held at reporting date | Mortgage banking activities | | | | | Trading account profit (loss) | | | | | Provision for credit losses | | | | | | | | | |
|
| Schedule of Significant Unobservable Inputs used to Derive the Fair Value of Level 3 Instruments |
The following tables include quantitative information about significant unobservable inputs used to derive the fair value of Level 3 instruments, excluding those instruments for which the unobservable inputs were not developed by the Corporation such as prices of prior transactions and/or unadjusted third-party pricing sources at June 30, 2026 and 2025. | | | | | | | Fair value at June 30, 2026 | | | | Weighted average (range) [1] | | | | Discounted cash flow model | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1]Weighted average of significant unobservable inputs used to develop Level 3 fair value measurements were calculated by relative fair value. [2]Loans held-in-portfolio in which haircuts were not applied to external appraisals were excluded from this table. | | | | | | | Fair value at June 30, 2025 | | | | Weighted average (range) [1] | | | | Discounted cash flow model | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1]Weighted average of significant unobservable inputs used to develop Level 3 fair value measurements were calculated by relative fair value. [2]Loans held-in-portfolio in which haircuts were not applied to external appraisals were excluded from this table.
|